follow us:
India’s drug regulator intensified checks on GLP-1 weight-loss drugs after inspecting 49 sites, including online pharmacies and clinics. Central Drugs Standard Control Organisation warned firms against public promotion. Nikhil Tandon urged caution over misuse, while authorities also began reviewing 90 unapproved FDCs to secure the supply chain.